Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Current Assets: 2014-2025

Historic Current Assets for Zevra Therapeutics (ZVRA) over the last 10 years, with Sep 2025 value amounting to $225.1 million.

  • Zevra Therapeutics' Current Assets rose 126.38% to $225.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $225.1 million, marking a year-over-year increase of 126.38%. This contributed to the annual value of $86.0 million for FY2024, which is 1.05% down from last year.
  • Latest data reveals that Zevra Therapeutics reported Current Assets of $225.1 million as of Q3 2025, which was down 0.54% from $226.3 million recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Current Assets registered a high of $226.3 million during Q2 2025, and its lowest value of $60.9 million during Q2 2024.
  • Over the past 3 years, Zevra Therapeutics' median Current Assets value was $99.4 million (recorded in 2024), while the average stood at $115.8 million.
  • Per our database at Business Quant, Zevra Therapeutics' Current Assets soared by 1,553.12% in 2021 and then crashed by 41.13% in 2024.
  • Zevra Therapeutics' Current Assets (Quarterly) stood at $115.1 million in 2021, then dropped by 19.31% to $92.8 million in 2022, then fell by 6.35% to $86.9 million in 2023, then declined by 1.05% to $86.0 million in 2024, then spiked by 126.38% to $225.1 million in 2025.
  • Its Current Assets stands at $225.1 million for Q3 2025, versus $226.3 million for Q2 2025 and $81.6 million for Q1 2025.